PFE - Valneva lowers 2025 financial outlook due to loss of Ixchiq vaccine marketing
2025-10-06 12:37:53 ET
More on Valneva
- Valneva Outlook: Safety Blow To Ixchiq And Valuation Concerns
- Valneva SE 2025 Q2 - Results - Earnings Call Presentation
- Valneva SE (VALN) Q2 2025 Earnings Call Transcript
- Valneva suspended from marketing chikungunya shot in U.S. over safety concerns
- Valneva reports 1H results; reaffirms FY outlook